XML 29 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net income (loss) $ 392,750 $ 57,875
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation, depletion and amortization 28,004 23,950
Loss (gain) on derivative instruments (40,343) 106,002
Cash settlements (paid) received on expired derivative instruments (8,273) (147,926)
Cash settlements received (paid) on terminated derivative instruments 658  
Deferred income tax expense (benefit) (253,796)  
Accretion of asset retirement obligations 7,951 7,081
Share-based compensation (see Note 11) 5,280 2,964
Settlement of asset retirement obligations (1,236) (923)
Amortization and write-off of deferred financing costs 1,980 649
Bad debt expense 98 1
Changes in operating assets and liabilities:    
Accounts receivable 41,262 2,815
Prepaid expenses and other assets (482) (3,957)
Payables and accrued liabilities (31,501) 13,812
Other (762) 2,142
Net cash provided by operating activities 141,590 64,485
Cash flows from investing activities:    
Additions to oil and gas properties (30,667) (34,814)
Additions to other property and equipment (711) (7)
Additions to restricted investments (8,609) (6,704)
Other 1,385  
Net cash used in investing activities (38,602) (41,525)
Cash flows from financing activities:    
Advances on Revolving Credit Facility 125,000 5,000
Payments on Revolving Credit Facility (200,000) (45,000)
Deferred financing costs (4,813) (1,196)
Shares withheld for taxes (2,429) (563)
Net cash used in financing activities (82,242) (41,759)
Net change in cash and cash equivalents 20,746 (18,799)
Cash and cash equivalents, beginning of period   $ 18,799
Cash and cash equivalents, end of period $ 20,746